Actuate Therapeutics, Inc. Common stock (ACTU) — Financial Flexibility Index
Actuate Therapeutics, Inc. Common stock (ACTU) has a Financial Flexibility Index of -0.99x as of September 2025. Free cash flow of $-6.68 Million (operating CF $-6.68 Million minus capex $3.00) represents -1% of total liabilities ($6.78 Million). Check Actuate Therapeutics, Inc. Common stock (ACTU) tangible net worth to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Actuate Therapeutics, Inc. Common stock Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for Actuate Therapeutics, Inc. Common stock across 3 annual periods. For the full cash flow conversion analysis, see how efficiently does Actuate Therapeutics, Inc. Common stock generate cash.
Annual Financial Flexibility Index for Actuate Therapeutics, Inc. Common stock (2022–2024)
Year-by-year free cash flow to debt coverage for Actuate Therapeutics, Inc. Common stock. Explore ACTU operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.37x | $-21.84 Million | $-21.84 Million | $9.21 Million | ▼ -1024.9% |
| 2023 | -0.21x | $-21.63 Million | $-21.63 Million | $102.62 Million | ▲ +93.3% |
| 2022 | -3.15x | $-17.79 Million | $-17.79 Million | $5.65 Million | — |